| Literature DB >> 32187186 |
Marie Lettau1,2, Annika Wiedemann1,2, Eva Vanessa Schrezenmeier1,2,3, Claudia Giesecke-Thiel4,5, Thomas Dörner1,2.
Abstract
BACKGROUND: Memory B cell (mBC) induction and maintenance is one of the keys to long-term protective humoral immunity. MBCs are fundamental to successful medical interventions such as vaccinations and therapy in autoimmunity. However, their lifestyle and anatomic residence remain enigmatic in humans. Extrapolation from animal studies serves as a conceptual basis but might be misleading due to major anatomical distinctions between species. METHODS ANDEntities:
Mesh:
Substances:
Year: 2020 PMID: 32187186 PMCID: PMC7080255 DOI: 10.1371/journal.pone.0229778
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Spleen and tonsil specimens used in the current study including underlying diagnosis and age of the donors.
| No. | Age [years] / sex | Diagnosis |
|---|---|---|
| Spleen specimens | ||
| S1 | 67 / unknown | Tumor nes |
| S2 | 45 / female | Splenomegaly and pancytopenia |
| S3 | 43 / female | Immunotrombocytopenia |
| S3 | 70 / unknown | Immunotrombocytopenia |
| S5 | 51 / unknown | Immunotrombocytopenia |
| S6 | Unknown / unknown | Immunotrombocytopenia |
| S7 | 20 / unknown | Immunotrombocytopenia |
| S8 | 16 / female | Cysts nes |
| S9 | 79 / female | Metastatic intestinal tumor nes |
| Tonsil specimens | ||
| T1 | 3 / female | Tonsillitis nes |
| T2 | 26 / female | Tonsillitis nes |
| T3 | 5 / male | Tonsillitis nes |
| T4 | 22 / female | Tonsillitis nes |
| T5 | 46 / male | Tonsillitis nes |
| T6 | 33 / male | Tonsillitis nes |
| T7 | 40 / male | Tonsillitis nes |
| T8 | 34 / female | Tonsillitis nes |
| T9 | 20 / female | Tonsillitis nes |
| T10 | Unknown / unknown | Unknown |
| T11 | Unknown / unknown | Unknown |
| T12 | Unknown / unknown | Unknown |
| T13 | Unknown / unknown | Unknown |
| T14 | Unknown / unknown | Unknown |
| T15 | Unknown / unknown | Unknown |
Nes = not elsewhere specified.
Primary and secondary antibodies used by the current study for multicolor immmunofluorescence microscopy.
| Conjugate | Clone | Isotype | Manufacturer | Acetone fixation | |
|---|---|---|---|---|---|
| Primary Abs | |||||
| Anti-IgA | FITC | M24A | Mouse IgG1 | Chemicon | After staining |
| Anti-IgD | BIO | IA6-2 | Mouse IgG2a | BD Pharmingen | After staining |
| PE | IA6-2 | Mouse IgG2a | BD Pharmingen | After staining | |
| FITC | IA6-2 | Mouse IgG2a | BD Pharmingen | After staining | |
| Anti-IgG | BIO | G18-145 | Mouse IgG1a | BD Pharmingen | After staining |
| Anti-IgM | Pure | Polyclonal | Rabbit | DAKO | Before staining |
| Anti-κ | BIO | G20-193 | Mouse IgG1a | BD Pharmingen | After staining |
| Anti-λ | BIO | JDC-12 | Mouse IgG1a | BD Pharmingen | After staining |
| Anti-CD3 | DIG | UCHT1 | Mouse IgG1 | DRFZ | After staining |
| PE | UCHT1 | Mouse IgG1 | DRFZ | After staining | |
| Anti-CD27 | FITC | M-T271 | Mouse IgG1 | BD Pharmingen | After staining |
| PE | M-T271 | Mouse IgG1 | BD Pharmingen | After staining | |
| Anti-CD20 | pure | Polyclonal | Rabbit | Thermo Scientific | Before staining |
| Anti-Ki67 | PE-Cy7 | B65 | Mouse IgG1 | BD Pharmingen | After staining |
| FITC | MIB-1 | Mouse IgG1 | DAKO | After staining | |
| Anti-MAdCAM-1 | DIG | 314G8 | Mouse IgG1 | Abcam | After staining |
| Secondary Abs | |||||
| SA | AF594 | Vector Laboratories | |||
| AF 633 | Invitrogen | ||||
| Anti-DIG | AF647 | DRFZ | |||
| Anti-Rabbit | AF594 | Donkey | Jackson Immunoresearch | ||
| AF647 | Donkey | Jackson Immunoresearch | |||
| FITC | Donkey | Jackson Immunoresearch | |||
| Anti-FITC | AF488 | Life Technologies | |||
| Anti-PE | TRITC | Acris | |||
Ab = antibody.
Conjugates: FITC = fluorescein isothiocyanate, BIO = biotin, PE = phycoerythrin, DIG = digoxigenin, PE-Cy7 = phycoerythrin-cyanin7, SA = Streptavidin, AF = Alexa Fluor, TRITC = tetramethylrhodamine.
Manufacturer: Chemicon, Tenecula, CA, USA; BD Pharmingen, Franklin Lakes, NJ, USA; DAKO, Glostrup, Denmark; German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany; Thermo Scientific, Waltham, MA, USA; Abcam, Cambridge, UK; Vector Laboratories, Burlingame, CA, USA; Invitrogen, Carlsbad, CA, USA; Jackson Immunoresearch, Cambridge, UK; Life Technologies, Carlsbad, CA, USA; Acris, Herford, Germany.
Distribution of LSM channels and dyes of the corresponding detection antibodies.
| Channel 1 | Channel 2 | Channel 3 | Channel 4 + Channel 5 | |
|---|---|---|---|---|
| DAPI | Mouse-Ab-ITC | Mouse-Ab-PE/PEcy7 | Mouse-Ab-DIG | Primary Abs |
| Mouse-Ab-BIO | ||||
| Ab (rabbit) | ||||
| Anti-FITC-AF488 | Anti-PE-TRITC | Anti-DIG-AF594/647 | Secondary Abs | |
| SA-AF594/633 | ||||
| Donkey-anti-rabbit-AF594/647 |
The five LSM channels used are arranged in ascending order of the fluorescence wavelength ranges with assignment of the Abs listed in Table 2. Ab = antibody.
Fig 1Histological identification of mBCs.
[human tonsil; 63x objective]. Human mBCs (single mBC exemplified in white box; localized near a secondary follicle portion) were defined as resting (Ki67- / channel 2 (fluorochrome a)), antigen-experienced (CD27+ / channel 3 (fluorochrome b)) B cells (CD20+ / channel 4 (fluorochrome c) and DAPI / channel 1). The additional channel 5 (fluorochrome d) serves for further characterization (κλ as example for mBC isotype characterization). Within the GC, intercellular signals may arise from immune complexes (IC) on the resident follicular dendritic cells.
Fig 2Human splenic symmetrical and asymmetrical secondary follicles.
[A-C: sections of human spleen (A = S8; B/C = S9); 20x objective]. White lines are drawn within and around the follicle for better orientation of follicular zones in the different channels. Main population of inner MZ (iMZ) and outer MZ (oMZ) are Ki67-CD27+CD20+ mBCs. At the MZ, instead of a clear border, mBC numbers are decreasing towards the red pulp and the FM. White arrows: Ki67-CD27-CD20+ naïve B cells in the red pulp transition. White circles: Branches of central artery. A: Representative example of a symmetrical secondary follicle. Ki67-CD27++CD3+ T cells appear lined-up in the middle of the MZ. Ki67+ cells are largely limited to the GC with no clear light zone (LZ) and dark zone (DZ) polarization. B: Asymmetrical secondary follicle. Polarization of the GC with Ki67 rich DZ orientation towards the PALS; MZ widening with increasing distance from the PALS (MZmax). C: MZ subdivision by MAdCAM-1. MAdCAM-1 expressed in a ring-like fashion splitting the MZ into an inner part (iMZ) directed to the GC and a MZ outer part (oMZ) directed to the red pulp.
Fig 3Class switched splenic mBCs are heterogeneously distributed in the superficial zone around the secondary follicle with few mBCs in the FM.
A [human spleen (S8); 20x objective]: White dashed lines within and around the follicle for better orientation of follicular zones in the different channels. The majority of MZ CD27+CD3- mBCs strongly expresses IgM, in the iMZ together with mostly only low or no surface IgD, in the oMZ mainly together with IgD (compare red circles). The number of IgM-IgD- mBCs increases in direction to the red pulp. CD27-CD3- naïve B cells in the red pulp transition show an increased signal for IgM and IgD (exemplified in yellow circles). White circles: Branches of central artery. B [human spleen (S8), 63x objective]: Heterogeneous distribution of IgG+ and IgA+ cells in the MZ and FM. Immunocomplexes in the GC.
Fig 4Expression of CD27 defines distinct areas in the tonsil.
White lines within and around the follicle are drawn for better orientation of follicular zones in the different channels. A: Overview of lymphocyte distribution in the human palatine tonsil, representative example. [Human tonsil; 10x objective]: Asymmetry of Ki67 rich DZ directed to the CD3+ IFR and a broadening FM directed to the SE. Crypt epithelium with a loose cell structure, many CD20+ B cells and only few Ki67+ proliferating cells compared to the squamous epithelium identified via Ki67+ cell rich area above basal lamina (white arrows). Superficial follicular CD27+CD20+Ki67- mBCs can already be displayed in this resolution by a mixed signal of CD27 and CD20 channel. B: Differentiation of lymphocyte populations according to their CD27 expression. [Human tonsil; 20x objective]: Four different CD27-FITC signal intensity zones (1 to 4) could be identified and in combination with Ki67, IgD, CD20 and κλ expression resulting main populations are indicated in the textbox (lower left).
Fig 5Switched tonsillar mBCs are heterogeneously distributed in the superficial zone and the FM.
White lines within and around the follicle are drawn for better orientation of follicular are drawn zones in the different channels. A: [Human tonsil; 10x objective] Serial section corresponding to Fig 4A. FM with mainly IgD+ naïve B cells. Bright extrafollicular intracellular IgG and IgA signal by PCs mainly in the SE, but also superficial follicular, in the IFR and the crypt epithelium. IgA+ or IgG+ and IgM+IgD+ mBCs, respectively, cannot be adequately resolved at this resolution; lower specific Ig signals can be identified primarily superficial follicular and in the FM. Unspecific bindings with vascular connective tissue especially in the IFR. Within the GC, intercellular signals may arise from immune complexes of the resident follicular dendritic cells. B: [Human tonsil; 20x objective]: White arrows mark the transition from crypt epithelium to SE. Bright extrafollicular intracellular IgG and IgA signal by PCs (exemplified in white circles). Heterogeneously distributed IgG+ and IgA+ cells in the SE, FM and epithelium. * Crypt lumen with detritus. C: [C1 human tonsil; 20x objective, C2 human tonsil; 63x objective]: Switched IgA+ and IgG+ mBCs are heterogeneously distributed in the superficial follicular zone (C1) and the FM (C2).